[USE AND ACTION OF THE NEW ANTIBIOTIC RIFAMYCIN SV (RIFOCIN)].
D000900:Anti-Bacterial Agents; D003428:Cross Infection; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D004358:Drug Therapy; D011013:Pneumonectomy; D012294:Rifamycins; D013203:Staphylococcal Infections; D013530:Surgical Wound Infection; D014116:Toxicology; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary
D000900:Anti-Bacterial Agents; D012294:Rifamycins; C023808:rifamycin SV
CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY; PNEUMONECTOMY; RIFOMYCIN; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION; TOXICOLOGIC REPORT; TUBERCULOSIS, PULMONARY
ANWENDUNG UND WIRKUNG DES NEUEN ANTIBIOTIKUMS RIFAMYCIN SV (RIFOCIN)